Evaluating Complication Rates in Post-Weight-Loss Body Contouring: Comparing Surgery, GLP-1 Pharmacotherapy, Combination, and Lifestyle Approaches
Highlight
The increasing use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has expanded non-surgical weight-loss options, generating interest in their impact on body-contouring surgical outcomes. This large retrospective cohort study compared complication rates following body-contouring procedures in patients with varied weight-loss backgrounds—bariatric surgery, injectable GLP-1 pharmacotherapy, combination therapy, and lifestyle modification. Notably, weight-loss modality did not influence the 90-day postoperative complication rate, while higher BMI at the time of surgery and presence of diabetes emerged as independent risk factors.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.